These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10653828)

  • 21. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
    Hjalmarson A; Goldstein S; Fagerberg B; Wedel H; Waagstein F; Kjekshus J; Wikstrand J; El Allaf D; Vítovec J; Aldershvile J; Halinen M; Dietz R; Neuhaus KL; Jánosi A; Thorgeirsson G; Dunselman PH; Gullestad L; Kuch J; Herlitz J; Rickenbacher P; Ball S; Gottlieb S; Deedwania P
    JAMA; 2000 Mar; 283(10):1295-302. PubMed ID: 10714728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of beta(1)-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: A double-blind, placebo-controlled, positron-emission tomography study.
    Beanlands RS; Nahmias C; Gordon E; Coates G; deKemp R; Firnau G; Fallen E
    Circulation; 2000 Oct; 102(17):2070-5. PubMed ID: 11044422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? The Heart Muscle Disease Study Group.
    DiLenarda A; Gregori D; Sinagra G; Lardieri G; Perkan A; Pinamonti B; Salvatore L; Secoli G; Zecchin M; Camerini F
    J Card Fail; 1996 Jun; 2(2):87-102. PubMed ID: 8798110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of carvedilol or metoprolol on left ventricular function in ischemic and nonischemic cardiomyopathy.
    Green P; Anshelevich M; Talreja A; Burcham JL; Ravi SM; Shirani J; Le Jemtel TH
    Am J Cardiol; 2005 May; 95(9):1114-6. PubMed ID: 15842987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF).
    Gottlieb SS; Fisher ML; Kjekshus J; Deedwania P; Gullestad L; Vitovec J; Wikstrand J;
    Circulation; 2002 Mar; 105(10):1182-8. PubMed ID: 11889011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of exercise capacity and left ventricular diastolic function with metoprolol XL after acute myocardial infarction.
    Poulsen SH; Jensen SE; Egstrup K
    Am Heart J; 2000 Jul; 140(1):E6-11. PubMed ID: 10874255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effect of beta-adrenergic blockade on left ventricular function in haemodialysis patients.
    Hara Y; Hamada M; Shigematsu Y; Murakami B; Hiwada K
    Clin Sci (Lond); 2001 Sep; 101(3):219-25. PubMed ID: 11524038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol.
    Sanderson JE; Chan SK; Yu CM; Yeung LY; Chan WM; Raymond K; Chan KW; Woo KS
    Heart; 1998 Jan; 79(1):86-92. PubMed ID: 9505927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale, design, and organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). The International Steering Committee.
    Am J Cardiol; 1997 Nov; 80(9B):54J-58J. PubMed ID: 9375952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
    Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR
    Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early reduction in plasma norepinephrine during beta-blocking therapy with metoprolol in chronic heart failure.
    Santostasi G; Fraccarollo D; Dorigo P; Egloff C; Miraglia G; Marinato PG; Villanova C; Fasoli G; Maragno I
    J Card Fail; 1998 Sep; 4(3):177-84. PubMed ID: 9754588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
    Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
    Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction.
    Rousseau MF; Chapelle F; Van Eyll C; Stoleru L; Hager D; Van Nueten L; Pouleur H
    J Card Fail; 1996 Mar; 2(1):15-23. PubMed ID: 8798100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade.
    Hall SA; Cigarroa CG; Marcoux L; Risser RC; Grayburn PA; Eichhorn EJ
    J Am Coll Cardiol; 1995 Apr; 25(5):1154-61. PubMed ID: 7897129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction.
    Stanek B; Frey B; Hülsmann M; Berger R; Sturm B; Strametz-Juranek J; Bergler-Klein J; Moser P; Bojic A; Hartter E; Pacher R
    J Am Coll Cardiol; 2001 Aug; 38(2):436-42. PubMed ID: 11499735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy.
    Currie PJ; Kelly MJ; McKenzie A; Harper RW; Lim YL; Federman J; Anderson ST; Pitt A
    J Am Coll Cardiol; 1984 Jan; 3(1):203-9. PubMed ID: 6140277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.
    Engelmeier RS; O'Connell JB; Walsh R; Rad N; Scanlon PJ; Gunnar RM
    Circulation; 1985 Sep; 72(3):536-46. PubMed ID: 3893793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.
    Hirooka K; Yasumura Y; Ishida Y; Hanatani A; Nakatani S; Komamura K; Hori M; Yamagishi M; Miyatake K
    Jpn Circ J; 2001 Nov; 65(11):931-6. PubMed ID: 11716241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.